Archives

photo: MUI/D. Bullock

photo: MUI/D. Bullock

photo: MUI/D. Bullock

Lisa Seekircher received the Dr. Otto Seibert award for her work “Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial“, which has been published in Lancet Microbe in 2023.

How should Europe deal with the COVID-19 pandemic in the future? Which strategies should be pursued and what specific risks should be considered? In September 2021, we published a call in the Lancet for closer European collaboration in addressing the COVID-19 pandemic. Together with this call in the Lancet, we published an expert opinion paper […]

This study evaluates the performance of the antigen based anterior nasal screening programme that was used at Austrian schools to detect SARS-CoV-2 infections. We combined nationwide antigen-based screening data obtained in March 2021 from 5,370 schools (Grade 1 to 8) with an RT-qPCR-based prospective cohort study comprising a representative sample of 244 schools. Considering a […]

There is much debate about the role of schools and children in the SARS-CoV-2 pandemic. In a consortium of four Austrian universities (Medical University of Innsbruck, Medical University of Graz, Medical Faculty of the JKU Linz, University of Vienna), we set out to reliably quantify the prevalence of SARS-CoV-2 infections at schools detected with reverse-transcription […]

Cardiometabolic diseases often occur in one and the same individual. In this paper published in JAMA, we aimed to estimate by how much life expectancy is reduced in individuals suffering from cardiometabolic multimorbidity. In our analysis, we calculated mortality rates and hazard ratios (HRs) adjusted for age and sex using individual participant data from the […]